Retinitis Pigmentosa Clinical Trials in Boston, MA

View the best 10 retinitis pigmentosa medical studies in Boston, Massachusetts. Access promising new therapies by applying to a Boston-based Retinitis Pigmentosa clinical trial.

Trials in Boston, Massachusetts

Here are the top 2 medical studies for retinitis pigmentosa in Boston, Massachusetts

AAV5-hRKp.RPGR

Virus Therapy

Recruiting1 awardPhase 2

This trial aims to test whether delivering a specific gene therapy directly under the retina is safe and well-tolerated in adults and children with a specific type of genetic eye disorder called X-linked retinitis

N-acetylcysteine

Antioxidant

Recruiting1 awardPhase 3

This trial is testing if N-acetylcysteine (NAC) can help slow down vision loss in people with Retinitis Pigmentosa (RP). RP is a genetic condition that causes gradual vision loss. NAC reduces damage caused by too much oxygen around eye cells, potentially protecting vision. N-acetylcysteine (NAC) has been shown to reduce oxidative damage and increase cone function/survival in studies related to RP.

Popular Filters

Trials With No Placebo

Virus Therapy

Gene Therapy for Retinitis Pigmentosa

Recruiting1 awardPhase 2

Boston, Massachusetts

This trial aims to test whether delivering a specific gene therapy directly under the retina is safe and well-tolerated in adults and children with a specific type of genetic eye disorder called X-linked retinitis

Gene Therapy

AGTC-501 for Retinitis Pigmentosa

Recruiting1 awardPhase 2

Boston, Massachusetts

This trial will test a new treatment for a genetic eye disorder called X-linked retinitis pigmentosa.

Gene Therapy

AGTC-501 for Retinitis Pigmentosa

Recruiting1 awardPhase 2

Boston, Massachusetts

This trial will test the safety of AGTC-501 in people with X-linked retinitis pigmentosa who have already received a gene therapy treatment for the condition.

Virus Therapy

AGTC-501 for Retinitis Pigmentosa

Recruiting1 awardPhase 2 & 3

Boston, Massachusetts

This trial will test two different doses of a gene therapy called AGTC-501 to see how safe and effective it is in treating a certain type of eye disease in men.

Gene Therapy

Gene Therapy for Retinitis Pigmentosa

Recruiting2 awardsPhase 3

Boston, Massachusetts

This trial tests a gene therapy for people with X-linked retinitis pigmentosa. It uses a harmless virus to deliver a healthy gene to eye cells, aiming to improve their function and slow down vision loss. Gene therapy targeting the RPE65 gene has shown promise in treating inherited retinal dystrophies, including retinitis pigmentosa.

Gene Therapy

Gene Therapy for Leber Congenital Amaurosis

Recruiting1 awardPhase 1 & 2

Boston, Massachusetts

This trial is testing a new gene therapy for people with a specific genetic mutation that causes Leber Congenital Amaurosis, a severe form of vision loss.

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.